158 related articles for article (PubMed ID: 37169960)
21. Pharmacological targeting of anaphylatoxin receptors during the effector phase of allergic asthma suppresses airway hyperresponsiveness and airway inflammation.
Baelder R; Fuchs B; Bautsch W; Zwirner J; Köhl J; Hoymann HG; Glaab T; Erpenbeck V; Krug N; Braun A
J Immunol; 2005 Jan; 174(2):783-9. PubMed ID: 15634899
[TBL] [Abstract][Full Text] [Related]
22. Human plasmacytoid dendritic cells express receptors for anaphylatoxins C3a and C5a and are chemoattracted to C3a and C5a.
Gutzmer R; Köther B; Zwirner J; Dijkstra D; Purwar R; Wittmann M; Werfel T
J Invest Dermatol; 2006 Nov; 126(11):2422-9. PubMed ID: 16778800
[TBL] [Abstract][Full Text] [Related]
23. Complement anaphylatoxins C3a and C5a: Emerging roles in cancer progression and treatment.
Ajona D; Ortiz-Espinosa S; Pio R
Semin Cell Dev Biol; 2019 Jan; 85():153-163. PubMed ID: 29155219
[TBL] [Abstract][Full Text] [Related]
24. The Complement C3a
Ren W; Liu Y; Wang X; Piao C; Ma Y; Qiu S; Jia L; Chen B; Wang Y; Jiang W; Zheng S; Liu C; Dai N; Lan F; Zhang H; Song WC; Du J
J Immunol; 2018 Mar; 200(5):1829-1838. PubMed ID: 29367209
[TBL] [Abstract][Full Text] [Related]
25. Mechanism of activation and biased signaling in complement receptor C5aR1.
Feng Y; Zhao C; Deng Y; Wang H; Ma L; Liu S; Tian X; Wang B; Bin Y; Chen P; Yan W; Fu P; Shao Z
Cell Res; 2023 Apr; 33(4):312-324. PubMed ID: 36806352
[TBL] [Abstract][Full Text] [Related]
26. New concepts on the therapeutic control of complement anaphylatoxin receptors.
Hawksworth OA; Li XX; Coulthard LG; Wolvetang EJ; Woodruff TM
Mol Immunol; 2017 Sep; 89():36-43. PubMed ID: 28576324
[TBL] [Abstract][Full Text] [Related]
27. Chimeric receptors of the human C3a receptor and C5a receptor (CD88).
Crass T; Ames RS; Sarau HM; Tornetta MA; Foley JJ; Köhl J; Klos A; Bautsch W
J Biol Chem; 1999 Mar; 274(13):8367-70. PubMed ID: 10085065
[TBL] [Abstract][Full Text] [Related]
28. Functional Relevance of the Anaphylatoxin Receptor C3aR for Platelet Function and Arterial Thrombus Formation Marks an Intersection Point Between Innate Immunity and Thrombosis.
Sauter RJ; Sauter M; Reis ES; Emschermann FN; Nording H; Ebenhöch S; Kraft P; Münzer P; Mauler M; Rheinlaender J; Madlung J; Edlich F; Schäffer TE; Meuth SG; Duerschmied D; Geisler T; Borst O; Gawaz M; Kleinschnitz C; Lambris JD; Langer HF
Circulation; 2018 Oct; 138(16):1720-1735. PubMed ID: 29802205
[TBL] [Abstract][Full Text] [Related]
29. Novel insights into the expression pattern of anaphylatoxin receptors in mice and men.
Laumonnier Y; Karsten CM; Köhl J
Mol Immunol; 2017 Sep; 89():44-58. PubMed ID: 28600003
[TBL] [Abstract][Full Text] [Related]
30. Regulation by complement C3a and C5a anaphylatoxins of cytokine production in human umbilical vein endothelial cells.
Monsinjon T; Gasque P; Chan P; Ischenko A; Brady JJ; Fontaine MC
FASEB J; 2003 Jun; 17(9):1003-14. PubMed ID: 12773483
[TBL] [Abstract][Full Text] [Related]
31. Expression of the complement anaphylatoxin C3a and C5a receptors on bronchial epithelial and smooth muscle cells in models of sepsis and asthma.
Drouin SM; Kildsgaard J; Haviland J; Zabner J; Jia HP; McCray PB; Tack BF; Wetsel RA
J Immunol; 2001 Feb; 166(3):2025-32. PubMed ID: 11160252
[TBL] [Abstract][Full Text] [Related]
32. The C3a/C3aR axis mediates anti-inflammatory activity and protects against uropathogenic E coli-induced kidney injury in mice.
Wu KY; Zhang T; Zhao GX; Ma N; Zhao SJ; Wang N; Wang JX; Li ZF; Zhou W; Li K
Kidney Int; 2019 Sep; 96(3):612-627. PubMed ID: 31133456
[TBL] [Abstract][Full Text] [Related]
33. Receptors for the anaphylatoxins C3a and C5a are expressed in human atherosclerotic coronary plaques.
Oksjoki R; Laine P; Helske S; Vehmaan-Kreula P; Mäyränpää MI; Gasque P; Kovanen PT; Pentikäinen MO
Atherosclerosis; 2007 Nov; 195(1):90-9. PubMed ID: 17234193
[TBL] [Abstract][Full Text] [Related]
34. Complement C3a enhances CXCL12 (SDF-1)-mediated chemotaxis of bone marrow hematopoietic cells independently of C3a receptor.
Honczarenko M; Ratajczak MZ; Nicholson-Weller A; Silberstein LE
J Immunol; 2005 Sep; 175(6):3698-706. PubMed ID: 16148115
[TBL] [Abstract][Full Text] [Related]
35. Interleukin-33 Amplifies Human Mast Cell Activities Induced by Complement Anaphylatoxins.
West PW; Bahri R; Garcia-Rodriguez KM; Sweetland G; Wileman G; Shah R; Montero A; Rapley L; Bulfone-Paus S
Front Immunol; 2020; 11():615236. PubMed ID: 33597949
[TBL] [Abstract][Full Text] [Related]
36. Expression of cytokines by human astrocytomas following stimulation by C3a and C5a anaphylatoxins: specific increase in interleukin-6 mRNA expression.
Sayah S; Ischenko AM; Zhakhov A; Bonnard AS; Fontaine M
J Neurochem; 1999 Jun; 72(6):2426-36. PubMed ID: 10349852
[TBL] [Abstract][Full Text] [Related]
37. Human C3a and C3a desArg anaphylatoxins have conserved structures, in contrast to C5a and C5a desArg.
Bajic G; Yatime L; Klos A; Andersen GR
Protein Sci; 2013 Feb; 22(2):204-12. PubMed ID: 23184394
[TBL] [Abstract][Full Text] [Related]
38. Neutraligands of C5a can potentially occlude the interaction of C5a with the complement receptors C5aR1 and C5aR2.
Das A; Ghosh M; Gupta PK; Rana S
J Cell Biochem; 2023 Feb; 124(2):266-281. PubMed ID: 36565188
[TBL] [Abstract][Full Text] [Related]
39. Interleukin-1 upregulates anaphylatoxin receptors on mononuclear cells.
Takabayashi T; Shimizu S; Clark BD; Beinborn M; Burke JF; Gelfand JA
Surgery; 2004 May; 135(5):544-54. PubMed ID: 15118592
[TBL] [Abstract][Full Text] [Related]
40. Negative regulation of pulmonary Th17 responses by C3a anaphylatoxin during allergic inflammation in mice.
Lim H; Kim YU; Drouin SM; Mueller-Ortiz S; Yun K; Morschl E; Wetsel RA; Chung Y
PLoS One; 2012; 7(12):e52666. PubMed ID: 23285141
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
